Bo Zhou

Bo Zhou is currently a Drug Development Advisor at Multiply Labs. Prior to that, they were Head of Pharmaceutical Product Development at Zogenix, Inc. from January 2018 to December 2021. Zogenix was acquired by UCB during their tenure. Bo has experience in both large and small pharmaceutical companies, giving their a unique perspective on drug development. Bo is an expert in the field and is highly sought-after for their advice and guidance.

Bo Zhou has a PhD in Industrial and Physical Pharmacy from Purdue University, an MS in Biological Engineering from Purdue University, and an Executive Education from Stanford University Graduate School of Business. Bo also has Extension Programs from the University of California, Berkeley.